NIH-funded research R01 grant

Understanding how super-enhancers influence retina development

Official title: The Role of Modular Super-Enhancers in the Developing Murine and Human Retina

Funded at St. Jude Children's Research Hospital · NIH-11145775 · Data updated 2026-11-12

This study is looking at how certain powerful parts of our DNA help shape the retina, which is important for vision, in both mice and humans, and it hopes to find out how changes in these parts might lead to eye diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startAugust 1, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$596,514
NIH project number5R01EY036689-02
Project IDNIH-11145775 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with genetic predispositions to retinal diseases or those experiencing unexplained vision problems.

Less likely to help

Patients with retinal conditions unrelated to genetic mutations or those who do not have a family history of retinal diseases may not benefit from this research.

What this research studies

This research investigates the role of super-enhancers in the development of the retina in both mice and humans. By mapping the interactions between these large regulatory elements and specific genes, the study aims to uncover how gene expression changes during the formation of different retinal cell types. The researchers utilize advanced techniques like single-cell RNA sequencing and ATAC-seq to analyze chromatin structure and gene regulation at a detailed level. This work could help identify genetic mutations that contribute to retinal diseases.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the genetic causes of retinal diseases, potentially informing future treatments.

How similar studies have gone: Previous research has shown promising results in understanding gene regulation through super-enhancers, indicating that this approach could yield valuable insights.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Dyer, Michael a — St. Jude Children's Research Hospital
  • Study coordinator: Dyer, Michael a

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.